s

About Academy  |  About IRBAS  |    Contact Us                                                                   ISSN (Online) : 2308-7056 | ISSN (Print) : 2710-0065

International Review of Basic
and Applied Sciences (IRBAS)

Home     Editorial Board     Current Issue     Archive     Indexing      Call for papers     Authors Guideline      Manuscript Submission      Contact

News & Events

Tuesday, April 01, 2025
IRBAS Volume 13, Issue 2 has been published.
  
Tuesday, April 01, 2025
IRBAS Volume 13, Issue 3, Quarter III of 2025 will publish in Jul-Aug 2025.
  
Monday, October 16, 2023
IRBAS is now HEC Recognized for the year 2023-2024
  
Saturday, December 03, 2022
IRBAS is now HEC Recognized in Category Y from 1st July 2022 till 30th June 2023.
  
Friday, August 06, 2021
IRBAS is now HEC Recognized in Category Y from 1st July 2021 till 30th June 2022.
  
Thursday, September 10, 2020
IRBAS Published on Quarterly basis from Volume 8.
  
Tuesday, January 17, 2017
Recruitment of Reviewers. Reviewers name and affiliation will be listed on the IRBAS journals webpage.
  

IRBAS Citation Report

  All Since 2025
 Citation  308 18
 h-index 10 01
 i10-index 11 01

Hit Counter

Total
Today's
Yesterday's

 Country Wise Counter

Academy Publication Ethics


Paper Details
Title

Evaluation of the Efficacy of Bacteriophages Targeting Multidrug-Resistant Staphylococcus aureus

AuthorsUSMAN ALI, AFSHAN SALEEM, IQBAL ALVI, MUHAMMAD HASSAN, ASMA ZAHOOR, HUMAIRA ARSHAD and RAFIA LIAQAT
Abstract

To address diseases brought on by bacteria that are resistant to antibiotics, bacteriophages—viruses that particularly target and destroy bacteria—are utilized as an alternative to antibiotics. In this study, phages from hospital sewage were isolated and characterized in relation to the clinical strain of multidrug-resistant Staphylococcus aureus. The phages were isolated and identified using biochemical methods, including coagulase tests, catalase tests, microscopy, and mannitol fermentation on mannitol salt agar. When antibiotic resistance was evaluated for these isolated bacteria, it was shown that all isolates had no resistance to Vancomycin, but they were 100% resistant to Augmentin, 68% to Ciprofloxacin, 53% to Cefotaxime, 50% to Cefixime, 33% to Streptomycin, 30% to Chloramphenicol, and 13% to Oxacillin. Consequently, specific phages identified as PA, PB, and PC were isolated and characterized for further study. The PA phage showed a broad host range in the host range analysis, lysing eight of the twenty different strains of Staphylococcus while not infecting any other bacteria. While a notable drop in titer was noted at pH levels 5 and 9, this phage maintained stability at temperatures as high as 60 °C and showed peak activity at pH 7. Investigating the biological properties of these phages can provide valuable insights and contribute to the development of potential therapeutic agents against multidrug-resistant Staphylococcus aureus.
Keywords: Bacteriophages, Antibiotic Resistance, MDR, Staphylococcus.

Volume 12
Issue July
Pages 111-120
File Name Download (82)
AUN

1730177593

Copyright © www.academyirmbr.com : 2012-25. All Rights Reserved.